This new assay of viral cell-mediated immunity is sensitive, reproducible, and in many ways resembles the in vivo state. The spread of herpes simplex virus between adjacent monolayer cells was inhibited in the presence of spleen cells from guinea pigs sensitized to that virus. This in vitro control of viral growth was quantified by determining plaque size in monolayers to which were added sensitized spleen cells as opposed to nonsensitized or no spleen cells. The simple measurement of plaque size reduction as an in vitro test of viral cell-mediated immunity is described. In addition to correlating highly with skin testing and macrophage migration inhibition as a test of viral cell-mediated immunity, the ability of sensitized spleen cells to reduce plaque size developed by day 7, paralleling the onset of delayed cutaneous hypersensitivity. The specificity of this lymphocyte-mediated interaction was demonstrated by the inability of herpes simplex virus-sensitized spleen cells to alter the growth of vaccinia virus in cell culture. A ratio of sensitized spleen cells to monolayer cells of 6:1 resulted in significant plaque size reduction on both HEp-2 and conjunctiva monolayers. The data presented demonstrate the potential usefulness of plaque size reduction as a technically simple, specific, and more direct measure of cellular antiviral activity.
The increasing appreciation of viral cellmediated immunity (CMI), especially in regard to pox-, herpes-, and papovaviruses (1), has led to a new importance being attached to the in vitro measurement of cellular immunity in virus infection. This interest is understandable in view of the frequency of opportunistic intracellular infection leading to death in the immunosuppressed host, the debility and despair accompanying recurrent viral disease in the otherwise immunocompetent host, and the viral role in the pathogenesis of autoimmune disease and the malignant transformation of cells. Simplv done, reliable in vitro methods with widespread availability are needed for the further evaluation and elucidation of viral delayed-type hypersensitivity (DTH) in man.
During the last decade several measures of CMI have been adapted to the study of virus infection, including the inhibition of both macrophage and explant migration by specific viral antigen (8, (10) (11) (12) (13) , blast cell transformation of sensitized lymphocytes in the presence of viral antigen (6, 7. 10, 13) , and lymphocyte-target cell cytotoxicity (4, 9, 13) . Although these methods have ushered in a new understanding of the host-virus relationship, they tend to be laborious and time-consuming, require expensive equipment and a high level of technical expertise, and may generate nonspecific responses produced by contaminating elements. In addition, the technical subtleties and varying sensitivities of different assay procedures have led to difficulty in reproducibility and interpretation (2) .
The present study was undertaken to determine the usefulness of plaque size and number reduction as a more direct in vitro assay for viral cellular immunity. This report, we feel, de Waldman and Henney (12) . After scarifice of the animals by cervical fracture, a ventral incision was made through the peritoneum and the spleen was removed. After mincing the spleens, the cells were filtered through sterile gauze with the aid of Hanks balanced salt solution (HBSS) containing heparin (5 U/ml). The cell suspension was centrifuged at 250 x g for 5 min at 4 C, and the sediment was resuspended and allowed to stand for 30 min at 4 C. The cells remaining in the supernatant were centrifuged at 250 x g for 5 min and then resuspended in 0.83% sterile NH4Cl for 10 min to lyse the erythrocytes. The remaining cells were centrifuged at 250 x g for 5 min, washed twice with HBSS without heparin, and counted on a hemocytometer utilizing trypan blue exclusion as a test of viability. Greater than 80% of the cells were routinely viable by this criterion.
(ii) Peritoneal exudate cells. These cells were used as the source of a migrating macrophage population. Peritoneal exudates were induced in nonsensitized guinea pigs by the intraperitoneal injection of 20 ml of light sterile mineral oil 72 h before sacrifice by cervical fracture. The peritoneal cavity was washed three times with 50 ml of HBSS with heparin (5 U/ml). The washings were collected and centrifuged, and the oil and supernatant were discarded. After the cells were resuspended in HBSS without heparin and washed twice, the number of viable cells was determined by hemocytometer counting using the trypan blue exclusion test.
Inhibition of macrophage migration. The technique for macrophage migration inhibition was adapted from Waldman and Henney (12) . Sensitized spleen cells were mixed with peritoneal exudate cells so that the final suspension contained 5 x 10' and 25 x 10' cells, respectively. Fifty lambda capillary tubes were filled with the cell suspension, sealed with Seal-Ease (Clay Adams, Parsippany, N.J.), centrifuged at 85 g for 4 min, cut at the cell-media interface, and placed in plastic tissue culture wells. For each experiment, six capillary tubes containing sensitized spleen cells were used. The chambers were filled with either minimal essential media with 10% fetal calf serum or the same media plus 300 Mg of soluble antigen. The wells were then kept in a CO2 incubator at 37 C for 24 h. To quantitate the extent of migration the tray of tissue culture wells containing the capillary fans was placed in an enlarger, and the magnified fans were traced on paper, cut out, and weighed. The percent of migration inhibition was calculated as: percent inhibition = (1 -mean area of migration with antigen)/(mean area of migration without antigen) x 100.
In each experiment nonsensitized cells were observed for normal migration in the presence of soluble antigen.
Plaque size and number reduction. The technique of plaque size and number reduction was adapted from Ennis (3). Conjunctiva and HEp-2 cell monolayers were grown in a 2-oz (ca. 56.7-g), 25-cm2 plastic bottles. The tissue culture cells were grown on basal minimal media with 20% fetal calf serum and 1% glutamine, with each milliliter containing 100 U of penicillin, 100 Mg of streptomycin, and 200 U of mycostatin. Both cell lines and all tissue culture media were purchased from Microbiological Associates, Bethesda, Md. The number of cells in a monolayer was determined after trypsinization by counting the trypan blue-excluding cells in one bottle. The monolayers were infected with 150 plaque-forming units of HSV-MP in 0.2 ml of HBSS and incubated at 37 C for 45 min with gentle rocking every 15 min. The monolayers were then washed twice with sterile phosphate-buffered saline. Spleen cells in a volume of 0.2 ml were then added, and the bottles were incubated for 45 min at 37 C with gentle rocking every 15 min. Control monolayers received no spleen cells, but were similarly incubated for 45 min at 37 C. At the end of the incubation period, 5 ml of minimal essential medium containing 1% methylcellulose, 10% fetal calf serum, 1% 200 mM glutamine, and sufficient 7.5% NaHCOs to bring the pH to 6.8 to 7.0 was added to each bottle. The cell layers were incubated at 37 C in a CO2 incubator for 48 to 72 h, i.e., until plaques on control monolayers were readily visible. The methylcellulose overlay was poured off, and the cell layers were stained with 0.1% crystal violet in 95% ethanol.
VOL. 10, 19714 The number of (Table 3 ). In a like manner, plaque size and number reduction have been found with spleen cells from animals sacrificed 7, 14, and 21 days after sensitization. Plaque size and number reduction were consistently observed in the presence of immune cells on both HEp-2 and human conjunctiva cells.
To study the optimal ratio of sentized spleen cells to monolayer cells four different concentrations were used. In contrast to a ratio of one spleen cell to one conjunctiva cell, a ratio of 6:1 showed ability to reduce plaque number and size as effectively as ratios of 20:1 and 50:1 a In a ratio of 6:1, spleen cells-monolayer cells. b Control plaques were present in monolayers to which no spleen cells had been added. c Not statistically significant. dp < 0.01 by analysis of variance.
( Table 4) . A ratio of 6:1 allowed full expression of the lymphocyte effect on HSV infection while using the least number of sensitized cells. In none of the groups was cytotoxicity of the monolayer cells evident at the end of 3 days. The specificity of plaque size reduction was then demonstrated. After adsorption of vaccinia virus to a conjunctiva monolayer for 45 min, spleen cells from guinea pigs sensitized to HSV were added. After 72 h plaque size and number determination revealed that HSV-sensitized cells failed to significantly alter the spread of vaccina virus in cell culture in contrast to the controlled growth of HSV-MP (Table 5) .
Finally, we endeavored to determine the cell type responsible for the in vitro inhibition of viral infection. Harvested spleen cells were allowed to stand in glass petri dishes for three successive periods of 30 min; after each period the supematant was poured into another dish, leaving the glass-adherent cells behind. This procedure allowed us to decrease the number of macrophages to less than 5% of the total spleen cell population at the end of 90 min. The cells were then added in a ratio of six lymphocytes to one conjunctiva cell to monolayers to which HSV-MP had been adsorbed. In contrast, other bottles received sensitized spleen cells prepared in the usual manner. The macrophage-depleted spleen cell population retained its ability to reduce plaque size and number ( Table 6 ), indicating that lymphocytes were primarily responsible for the plaque size reduction.
DISCUSSION
In vitro tests of viral CMI currently play an important role in delineating the interplay between host and virus in the disease state. They are methodological variations measuring either lymphocyte-mediated cytotoxicity, lymphokine production, especially migration inhibition fac- Ennis, a macrophage-depleted spleen cell population retained the ability to limit the spread of HSV infection. Studies are currently underway in our laboratory to further investigate the ability of sensitized lymphocytes to limit the spread of viral infection.
The technique of plaque size and number reduction provides a potent tool for measuring viral CMI in vitro. The data presented show that the cellular immune reaction to HSV infection in the guinea pig can be measured in vitro by this method. Plaque size and number reduction correlate well with skin testing and inhibition of macrophage migration, in addition to being specific, sensitive, and reproducible. Moreover, this in vitro method is a simpler and more straightforward measurement of antiviral CMI-in many respects resembling the in vivo state. 
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